| Literature DB >> 26139843 |
Yutaka Yamamoto1, Jacob Bliss1, Susan A Gerbi2.
Abstract
Targeted gene insertion is a goal of genome editing and has been performed in cultured cells but only in a handful of whole organisms. The existing method to integrate foreign DNA using the homologous recombination pathway is inherently low efficiency, and many systems are refractory to this method. Several additional manipulations have been developed to gain greater efficiency by suppressing the competing dominant repair pathway of nonhomologous end-joining. However, this can be laborious and in practice limits the range of hosts where the method is applicable. Here, we use the preferred pathway of nonhomologous end-joining (used previously to create indels for gene inactivation) for precise integration of large DNA into the specified genomic target site of an intact animal. Our method uses site-specific cleavage, end-capture of cohesive ends, and obligate ligation-gated recombination. This approach is straight-forward and yields high efficiency without additional gene manipulations; therefore it is easily applicable to a much broader range of organisms. We demonstrate its application to the fungus fly Sciara coprophila where a transformation system has not existed before. We integrated a 6.5 kb transgene precisely at the desired genomic target site of Sciara using this method. This provides the foundation for future experiments to explore the unique genetic features of this organism. Similarly, the method described here will allow insertion of large pieces of DNA into a diverse group of organisms for studies of their genetic attributes.Entities:
Keywords: ObLiGaRe; genome editing; nonhomologous end-joining (NHEJ)
Mesh:
Substances:
Year: 2015 PMID: 26139843 PMCID: PMC4555220 DOI: 10.1534/g3.115.019901
Source DB: PubMed Journal: G3 (Bethesda) ISSN: 2160-1836 Impact factor: 3.154
Figure 1Somatic targeted gene insertion using ZFNs with ObLiGaRe. (A) Schematic for somatic integration at Sciara DNA puff II9/A, showing the nt 2660 cleavage site upstream of the amplification origin (Amp.ORI). (B) The principle of targeted gene insertion into nt 2660 of Sciara locus II/9A using an ObLiGaRe donor construct. ZFN binding sites (filled or open circles), wild-type (wt) or inverted sequence (iv) orientations, genomic DNA (solid line), cloning vector pIDTSmart (heavy black line) and linker sequence of the donor construct (dashed line) are indicated. The linker sequence (see File S1 for sequence) contains loxP, attP, and FRT site-specific recombination sites (gray triangle) for enhanced versatility and potential use in future experiments. (C) Polymerase chain reaction (PCR) primer pairs are shown along with the expected PCR products of 510 bp (wt) and 2360 bp (transformed) using genomic DNA from injected embryos. (D) Gel of the genomic PCR products (lane 1: wt, wild-type; lane 2: inj, injected). (E) Sequence alignment of the junction between the genomic DNA and the integrated donor DNA in clones containing the 2360 bp PCR fragment. The 12 bp inverted sequences of 2660iv are underlined and capital letters show the 9 bp ZFN-binding sites; the linker sequence at the ZFN target site is shown in bold. Each of the 30 clones that were sequenced was named with a number (indicated).
Figure 2Germline inherited targeted gene insertion using ZFNs with ObLiGaRe. (A) Schematic of the injection and subsequent screening of the germline transgenes using Blasticidin resistance as the selection marker. The asterisk indicates a candidate transgenic G1 female. (B) The transgene for the germline integration contains two marker genes (3XP3-TATA-TagYFP-PolyA, hr5-ie1-BlasR-PolyA) and site-specific recombination target sequences loxP-attP-FRT (gray triangle) for potential use in future experiments. Polymerase chain reaction (PCR) fragments including junction between genomic DNA and inserted donor DNA are shown as a line with PCR primer-pairs indicated for the left junction (LJ: 1340 bp) and right junction (RJ: 1465 bp). The 1.5 kb DNA hybridization probe (black rectangle) is complementary to sequences within a 3.0 kb EcoR1 genomic fragment from transformed Sciara. (C, D) Gel photos of the genomic PCR products (Lanes 1-4: genomic DNA extracted from four independent transgenic lines; Lane 5: genomic DNA from uninjected control). (C) Left junction 1340 bp PCR products. (D) Right junction 1465 bp PCR products. (E) Left panel: Gel of EcoRI-digested genomic DNA before transfer. Right panel: Genomic Southern blot using the 1.5 kb fragment of the integration marker as the probe. Lane 1: uninjected control DNA, lane 2: mixture of genomic DNA from four independent transgenic lines.